CCMH
EGRX

Cornerstone Capital Management Holdings’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$345K Buy
6,471
+100
+2% +$5.57K ﹤0.01% 1062
2017
Q3 		$379K Buy
6,371
+300
+5% +$18.1K ﹤0.01% 1094
2017
Q2 		$478K Sell
6,071
-105
-2% -$8.59K ﹤0.01% 1045
2017
Q1 		$511K Buy
+6,176
New +$459K ﹤0.01% 1057
2015
Q4 		– Sell
-1,000
Closed -$74K – 1548
2015
Q3 		$74K Buy
+1,000
New +$83.2K ﹤0.01% 1369

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cornerstone Capital Management Holdings's EGRX Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Eagle Pharmaceuticals, Inc. (EGRX) stake by 1.6% in Q4 2017, buying an estimated $5.57K and bringing the position to 6,471 shares worth $345K. The position accounts for ﹤0.01% of the portfolio, ranked #1062.

Cornerstone Capital Management Holdings first reported a position in EGRX in Q3 2015 and has held it in 5 quarters since. The position peaked at $511K in Q1 2017. 170 funds tracked by Wall St. Rank hold EGRX as of Q4 2017.

  • Cornerstone Capital Management Holdings held 6,471 shares of Eagle Pharmaceuticals, Inc. worth $345K as of Q4 2017.
  • Cornerstone Capital Management Holdings bought 100 Eagle Pharmaceuticals, Inc. shares in Q4 2017, an estimated $5.57K.
  • Eagle Pharmaceuticals, Inc. made up ﹤0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #1062 holding.
  • Cornerstone Capital Management Holdings first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2015 and has held it in 5 quarters since.
  • Cornerstone Capital Management Holdings's Eagle Pharmaceuticals, Inc. position peaked at $511K in Q1 2017.
  • 170 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.